Introduction Semaglo SC Injection 0.25 mg/0.188 ml is a glucagon-like peptide 1 (GLP-1) analog used to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity
Currently available FDA-approved GLP-1 RAs include several monotherapy agents and one combination multi-agonist, the dual GLP-1/GIP agonist tirzepatide (Zheng et al., 2024)
Competitive Pricing: We offer attractive pricing for bulk purchases, allowing you to maximize your research budget
Source: Rubino D, Abrahamsson N, Davies M, et al
Kidney problems: People with preexisting kidney problems may experience worsened kidney function due to dehydration caused by diarrhea, nausea, or vomiting
Without objective confirmation, do not assign K59.01